glycoprotein
avian
coronaviru
infecti
bronchiti
viru
ibv
contain
inform
local
ci
golgi
network
first
transmembran
domain
hypothes
local
golgi
complex
may
depend
part
specif
interact
protein
transmembran
domain
membran
lipid
site
sphingolipid
synthesi
overlap
local
ibv
ask
whether
perturb
sphingolipid
affect
local
ibv
shortterm
treatment
two
inhibitor
sphingolipid
synthesi
effect
local
ibv
golgi
marker
thu
ongo
synthesi
lipid
requir
proper
local
surprisingli
third
inhibitor
pdmp
shift
steadyst
distribut
ibv
golgi
complex
er
effect
rapid
revers
also
observ
golgi
stack
protein
concentr
pdmp
use
convers
ceramid
glucosylceramid
sphingomyelin
inhibit
pretreat
upstream
inhibitor
partial
revers
effect
pdmp
suggest
ceramid
accumul
mediat
pdmpinduc
alter
inde
increas
cellular
ceramid
measur
pdmptreat
cell
propos
ibv
least
part
local
retriev
mechan
ceramid
accumul
reveal
cycl
upset
balanc
anterograd
retrograd
traffic
disrupt
retent
alter
bilay
dynam
organel
classic
secretori
pathway
must
maintain
ident
despit
larg
flux
lipid
protein
two
model
emerg
explain
protein
maintain
specif
compart
macham
nilsson
warren
retent
model
propos
protein
effici
anchor
appropri
compart
retriev
model
propos
protein
continu
recycl
later
compart
two
model
mutual
exclus
inde
protein
within
secretori
pathway
probabl
use
mechan
local
albeit
differ
extent
exampl
local
er
resid
protein
bip
contain
kdel
retriev
signal
slowli
secret
signal
remov
munro
pelham
suggest
part
molecul
may
contain
retent
inform
glycoprotein
avian
coronaviru
infecti
bronchiti
viru
ibv
model
protein
studi
local
earli
secretori
pathway
immunoelectron
microscopi
show
ibv
express
absenc
ibv
protein
found
tubulovesicular
structur
entri
ci
face
golgi
stack
well
first
second
cisterna
golgi
stack
macham
et
al
sodeik
et
al
refer
region
ci
golgi
network
cgn
mellman
simon
defin
way
would
consid
cgn
least
partial
overlap
intermedi
compart
ic
defin
marker
schweizer
et
al
lahtinen
et
al
first
transmembran
domain
ibv
suffici
target
chimer
protein
cgn
swift
macham
macham
et
al
although
transmembran
domain
golgi
protein
also
contain
target
inform
consensu
motif
local
identifi
review
see
colley
intrigu
possibl
target
golgi
membran
protein
may
part
depend
interact
transmembran
domain
specif
membran
lipid
independ
studi
demonstr
lipid
composit
membran
differ
stage
secretori
pathway
keenan
morr
cluett
et
al
review
see
van
meer
sphingolipid
includ
sphingomyelin
sm
glucosylceramid
glccer
precursor
gangliosid
one
class
lipid
thought
increas
rel
concentr
secretori
pathway
ceramid
precursor
sphingolipid
synthes
er
rat
liver
ceramid
convert
differ
class
sphingolipid
enzym
local
cgn
ci
medial
golgi
cisterna
futerman
et
al
futerman
pagano
express
recombin
vaccinia
viru
ibv
local
cgn
sever
cell
type
local
presum
overlap
sm
glccer
synthas
activ
led
us
specul
may
link
sphingolipid
synthesi
local
ibv
address
question
test
effect
three
sphingolipid
synthesi
inhibitor
steadyst
local
ibv
observ
dramat
redistribut
ibv
induc
one
inhibitor
glucosylceramid
analogu
pdmp
use
upstream
inhibitor
coupl
lipid
analysi
suggest
pdmp
effect
mediat
accumul
precursor
ceramid
ibv
induc
move
er
propos
ibv
least
part
local
retriev
mechan
fc
atlanta
biolog
norcross
ga
fumonisin
calbiochem
la
jolla
ca
chromatographi
plate
e
merck
darmstadt
germani
endoglycosidas
h
endo
h
new
england
biolab
beverli
n
hexanoylsphingosin
c
cer
lipid
standard
pdmp
matreya
pleasant
gap
pa
h
palmit
cimmol
dupontnen
wilmington
de
promix
mcimmol
methionin
amersham
intl
arlington
height
il
dme
tissu
culturegrad
trypsin
penicillinstreptomycin
gibco
brl
gaithersburg
md
reagent
sigma
chemic
co
st
loui
mo
antibodi
obtain
follow
monoclon
antibip
stressgen
victoria
bc
canada
monoclon
antigiantin
monoclon
hanspet
hauri
basel
switzerland
polyclon
cop
jennif
lippincottschwartz
nation
institut
health
bethesda
md
polyclon
mannosidas
ii
marilyn
farquhar
univers
california
san
diego
la
jolla
ca
kelley
moreman
univers
georgia
athen
ga
polyclon
antibodi
ibv
vesicular
stomat
viru
vsv
prepar
describ
macham
rose
weisz
et
al
respect
texa
redand
fitcconjug
secondari
antibodi
jackson
immunoresearch
west
grove
pa
cell
cultur
tissu
cultur
cell
grown
dme
supplement
vero
fc
cell
grown
c
atmospher
co
pulsechas
label
pulsechas
experi
perform
previous
describ
rosenwald
et
al
weisz
et
al
briefli
cell
plate
dish
night
experi
confluent
next
day
vsv
san
juan
strain
indiana
serotyp
adsorb
min
ml
serumfre
dme
h
infect
cell
starv
methionin
min
cell
puls
min
ci
spromix
chase
indic
amount
time
presenc
absenc
indic
drug
isopropanol
carrier
alon
effect
rate
transport
vsv
g
protein
chase
cell
wash
cold
pb
lyse
deterg
vsv
g
protein
immunoprecipit
treat
endo
h
describ
rosenwald
et
al
separ
sdspage
visual
fluorographi
endo
hsensit
resist
form
vsv
g
protein
quantit
densitometri
indirect
immunofluoresc
microscopi
experi
perform
previous
describ
swift
macham
briefli
cell
infect
min
recombin
vaccinia
viru
encod
ibv
indic
treatment
begun
h
infect
experi
use
exogen
ceramid
solubl
shortchain
analogu
ceramid
ad
cell
complex
mgml
defat
bsa
describ
pagano
martin
treatment
cell
fix
permeabil
stain
appropri
antibodi
imag
acquir
use
microscop
axioskop
zeiss
inc
thornwood
ny
equip
epifluoresc
ccd
camera
photometr
sensi
tucson
az
use
ip
lab
softwar
signal
analyt
corp
vienna
va
imag
shown
raw
data
collect
bin
gain
lipid
synthesi
assay
cell
seed
onto
plastic
dish
experi
confluent
day
experi
cell
incub
dme
supplement
gml
cycloheximid
half
dish
also
incub
mm
ca
h
later
fresh
medium
contain
cycloheximid
h
palmit
ci
dish
ad
along
either
isopropanol
control
ca
pdmp
mm
ca
indic
h
later
cell
trypsin
wash
plate
ml
cold
pb
normal
lipid
level
l
remov
protein
assay
method
bradford
lipid
extract
method
bligh
dyer
label
sampl
dope
g
cold
ceramid
allow
visual
sampl
run
cm
high
perform
thinlay
chromatographi
plate
mobil
phase
chloroformglaci
acet
acid
abe
et
al
plate
spray
water
visual
ceramid
band
scrape
count
addit
scintil
fluid
altern
plate
dip
chloroform
visual
fluorographi
henderson
tocher
test
whether
ongo
sphingolipid
synthesi
necessari
correct
local
ibv
protein
use
three
inhibitor
sphingolipid
synthesi
chloroalanin
ca
medlock
merril
fumonisin
wang
et
al
pdmp
vunnam
radin
inokuchi
radin
biosynthet
pathway
sphingolipid
site
inhibit
drug
shown
fig
ca
mm
inhibit
incorpor
radiolabel
precursor
sphingolipid
cell
data
shown
consist
previou
result
rosenwald
et
al
found
pdmp
inhibit
glccer
synthesi
sm
synthesi
cell
data
shown
express
ibv
protein
cell
infect
recombin
vaccinia
viru
encod
ibv
macham
rose
h
infect
cell
treat
cycloheximid
h
chase
newli
synthes
protein
er
sphingolipid
synthesi
inhibitor
ad
cell
incub
anoth
h
process
immunofluoresc
fig
control
cell
ibv
exhibit
tight
juxtanuclear
stain
pattern
coloc
golgi
marker
golgi
local
pattern
ibv
unchang
treatment
either
ca
suggest
ongo
sphingolipid
synthesi
requir
proper
local
ibv
contrast
pdmptreat
cell
show
mark
chang
stain
pattern
ibv
protein
h
local
ibv
presenc
pdmp
chang
golgi
er
base
absenc
strong
juxtanuclear
stain
presenc
nuclear
rim
stain
tubuloreticular
stain
pattern
coloc
er
marker
treatment
infect
cell
lower
concentr
pdmp
effect
ibv
local
littl
effect
sm
synthesi
data
shown
next
test
kinet
pdmpinduc
misloc
ibv
cell
infect
treat
h
cycloheximid
cell
treat
pdmp
vari
length
time
h
fig
redistribut
first
observ
min
becam
maxim
min
redistribut
rapidli
revers
min
wash
pdmp
ibv
move
back
golgi
region
next
ask
pdmp
misloc
golgi
marker
cell
infect
treat
describ
stain
antibodi
two
integr
membran
protein
golgi
stack
giantin
linstedt
hauri
mannosidas
ii
man
ii
moremen
robbin
velasco
et
al
treatment
cell
pdmp
h
effect
local
either
protein
fig
suggest
morpholog
golgi
greatli
alter
also
examin
local
cop
peripher
membran
protein
stack
cgn
involv
vesicular
traffic
oprin
et
al
seen
fig
distribut
cop
appear
unaffect
treat
cell
look
protein
cycl
ci
golgi
access
antibodi
crossreact
known
marker
cell
examin
vero
cell
ibv
local
cgn
cell
also
redistribut
er
pdmp
data
shown
ic
protein
cycl
er
ic
golgi
stack
lippincottschwartz
et
al
schindler
et
al
vero
cell
treat
gml
cycloheximid
h
pdmp
ad
dish
fix
indic
time
prepar
indirect
immunofluoresc
h
pdmp
remain
dish
wash
three
time
ml
dme
serum
incub
cycloheximidecontain
medium
indic
time
prepar
indirect
immunofluoresc
experiment
seri
nomarski
imag
shown
left
fluoresc
imag
right
bar
cycloheximid
h
without
pdmp
addit
hour
fix
prepar
immunofluoresc
fig
similar
effect
ibv
pdmp
treatment
shift
steadyst
distribut
er
addit
neither
ca
effect
local
data
shown
immunofluoresc
result
suggest
pdmp
might
gener
alter
distribut
protein
dynam
local
mechan
interestingli
shown
pdmp
slow
rate
anterograd
vesicular
traffic
rosenwald
et
al
endocytosi
chen
et
al
cho
cell
test
whether
pdmp
also
slow
anterograd
traffic
cell
use
plasma
membran
protein
wellcharacter
g
protein
vsv
pulsechas
experi
perform
either
presenc
absenc
pdmp
ca
rate
accumul
endo
hresist
vsv
g
use
assay
rate
arriv
medial
golgi
neither
ca
effect
rate
anterograd
traffic
howev
pdmp
increas
halftim
transport
min
fig
fig
show
neither
ca
effect
transit
rate
vsv
g
suggest
decreas
rate
pdmp
due
block
ongo
synthesi
sphingolipid
pdmp
inhibit
convers
ceramid
glycosphingolipid
sphingomyelin
one
possibl
explan
effect
observ
pdmp
accumul
precursor
ceramid
ca
act
upstream
pdmp
fig
intermedi
sphingolipid
synthesi
step
ceramid
product
thought
short
live
merril
wang
medlock
merril
ask
ceramid
accumul
might
mediat
pdmpinduc
slow
anterograd
traffic
cell
treat
ca
pdmp
perform
pulsechas
label
experi
cell
pretreat
either
ca
h
chase
presenc
absenc
ca
pdmp
fig
pretreat
earlier
inhibitor
reduc
pdmpinduc
slow
anterograd
traffic
half
suggest
accumul
newli
synthes
ceramid
least
partial
mediat
effect
test
whether
ceramid
like
mediat
pdmpinduc
misloc
ibv
indirect
immunofluoresc
perform
cell
pretreat
either
ca
h
addit
pdmp
simplifi
quantif
local
ibv
classifi
one
three
stain
pattern
class
commonli
seen
pattern
untreat
cell
ie
tight
juxtanuclear
stain
coloc
golgi
marker
class
commonli
seen
pattern
pdmptreat
cell
ie
diffus
stain
promin
nuclear
envelop
stain
coloc
er
marker
class
intermedi
class
class
whether
pattern
repres
overlap
er
golgi
stain
pattern
increas
ic
stain
clear
experi
code
sampl
quantifi
count
least
cell
sampl
experi
perform
five
time
one
repres
experi
shown
fig
interestingli
cell
quantifi
way
observ
ca
caus
slight
shift
class
class
signific
observ
clear
pdmp
dramat
shift
distribut
ibv
mainli
class
control
cell
mainli
class
pretreat
either
ca
significantli
reduc
shift
stain
pattern
ibv
suggest
accumula
figur
pdmp
induc
redistribut
endogen
ic
protein
er
vero
cell
incub
cycloheximid
h
incub
h
presenc
either
isopropanol
control
pdmp
cell
fix
prepar
indirect
immunofluoresc
antibodi
experiment
group
nomarski
imag
shown
left
fluoresc
imag
right
bar
pretreat
experi
suggest
increas
level
ceramid
mediat
pdmpinduc
effect
ibv
local
ceramid
act
second
messeng
review
see
hannun
suggest
mediat
effect
pdmp
cho
cell
rosenwald
pagano
furthermor
sever
system
cellular
level
ceramid
increas
upon
treatment
pdmp
one
solubl
analogu
exampl
see
rani
et
al
poss
de
chave
et
al
measur
level
ceramid
variou
treatment
pulselabel
h
palmit
label
treatment
cellular
lipid
extract
run
chromatographi
plate
appropri
spot
correspond
ceramid
scrape
count
consist
hypothesi
fig
show
pdmp
treatment
increas
level
ceramid
control
level
pretreat
ca
reduc
pdmpinduc
ceramid
accumul
roughli
half
control
level
level
still
threefold
higher
cell
treat
ca
alon
fig
b
repres
fluorograph
show
ceramid
region
quantifi
fig
interestingli
notic
appear
lower
migrat
ceramid
band
pdmptreat
cell
pretreat
experi
well
lipid
analysi
implic
ceramid
mediat
pdmp
effect
true
addit
solubl
shortchain
analogu
ceramid
might
mimic
effect
pdmp
inde
one
cellperm
analogu
ceramid
n
hexanoylsphingosin
c
cer
reproduc
effect
pdmp
anterograd
traffic
vsv
g
cho
cell
rosenwald
pagano
first
ask
whether
c
cer
slow
anterograd
traffic
cell
pulsechas
label
experi
vsvinfect
cell
perform
cell
chase
absenc
presenc
c
cer
c
cer
slow
rate
anterograd
traffic
cell
data
shown
went
use
c
cer
indirect
immunofluoresc
assay
expect
c
cer
effect
local
either
man
ii
fig
howev
contrari
expect
c
cer
alter
local
either
ibv
suggest
exogen
ad
c
cer
ceramid
gener
treatment
pdmp
effect
two
solubl
analogu
ceramid
c
cer
c
cer
also
test
found
effect
local
ibv
data
shown
two
possibl
mechan
maintain
steadyst
local
protein
specif
site
along
secretori
pathway
retent
particular
compart
b
retriev
compart
macham
nilsson
warren
redistribut
ibv
induc
pdmp
surpris
expect
disrupt
local
would
move
bulk
flow
plasma
membran
ibv
redistribut
er
suggest
specif
target
inform
retriev
er
coupl
earlier
work
laboratori
role
oligomer
ibv
chimera
cgn
target
weisz
et
al
find
suggest
ibv
maintain
steadyst
distribut
retent
retriev
fig
propos
two
model
explain
redistribut
ibv
protein
induc
pdmp
simplest
model
fig
b
left
arrow
protein
normal
cycl
er
golgi
signific
rate
shown
lippincottschwartz
et
al
schindler
et
al
slow
anterograd
traffic
would
caus
protein
shift
steadyst
distribut
er
assum
retrograd
traffic
unaffect
perhap
increas
pdmp
second
possibl
pdmp
disrupt
retent
protein
cycl
back
er
normal
retriev
mechan
fig
b
right
arrow
two
model
mutual
exclus
effect
pdmp
may
necessari
redistribut
ibv
extent
observ
implicit
model
idea
ibv
contain
retriev
inform
pdmpinduc
er
redistribut
also
observ
dilysinecontain
ic
marker
known
cycl
er
lippincottschwartz
et
al
schindler
et
al
doublelabel
immunoelectron
microscopi
hela
cell
show
distribut
ibv
overlap
significantli
though
complet
sodeik
et
al
suggest
ibv
may
part
use
yet
unknown
cellular
machineri
use
ic
protein
maintain
steadyst
local
use
delet
mutant
chimer
molecul
dissect
ibv
retent
retriev
inform
possibl
use
pdmp
tool
pathway
follow
ibv
retriev
also
import
deciph
experi
nontreat
cell
suggest
protein
may
move
later
golgi
compart
even
though
steadyst
distribut
cgn
oligosaccharid
slowli
process
macham
et
al
interestingli
observ
redistribut
two
golgi
stack
marker
man
ii
giantin
er
pdmp
treatment
golgi
membran
protein
recent
suggest
highli
mobil
cole
et
al
cycl
er
cole
et
al
result
pdmp
suggest
cycl
protein
occur
time
scale
experi
andor
predomin
effect
ibv
loss
retent
interestingli
shown
myriocin
inhibitor
sphingolipid
synthesi
thought
inhibit
step
reduc
rate
transport
glycosylphosphatidylinositollink
protein
protein
er
yeast
horvath
et
al
would
interest
test
whether
inhibit
ceramid
synthesi
mammalian
cell
also
slow
rate
transport
glycosylphosphatidylinositollink
protein
mammalian
cell
howev
neither
effect
rate
anterograd
traffic
vsv
g
local
ic
cgn
golgi
stack
protein
quantifi
effect
two
inhibitor
immunofluoresc
figur
exogen
c
cer
redistribut
ibv
bhk
cell
ibv
man
ii
vero
cell
infect
recombin
vaccinia
viru
express
ibv
h
infect
cell
treat
gml
cycloheximid
h
infect
cell
incub
h
serumfre
dme
mgml
defat
bsa
without
c
cer
cell
prepar
indirect
immunofluoresc
stain
indic
antibodi
experiment
seri
nomarski
imag
shown
left
fluoresc
imag
right
bar
figur
current
model
ibv
maintain
steadyst
distribut
pdmp
might
alter
distribut
evid
present
show
ibv
induc
redistribut
er
indic
ibv
inform
necessari
traffic
er
propos
ibv
normal
maintain
steadyst
distribut
cycl
er
basal
rate
b
ibv
cycl
er
normal
local
would
depend
balanc
anterograd
retrograd
traffic
rate
pdmp
slow
anterograd
traffic
ibv
could
accumul
er
balanc
membran
traffic
disrupt
left
arrow
altern
pdmp
may
act
disrupt
retent
ibv
caus
move
golgi
right
arrow
also
possibl
redistribut
ibv
requir
effect
pdmp
stain
pattern
ibv
detect
slight
shift
toward
intermedi
stain
pattern
fig
whether
repres
alter
distribut
pattern
subtl
effect
golgi
structur
caus
inhibitor
unclear
result
conclud
ongo
sphingolipid
synthesi
requir
either
normal
rate
anterograd
traffic
proper
local
golgi
protein
howev
glucosylceramid
analogu
pdmp
concentr
inhibit
glccer
sm
synthas
caus
redistribut
ibv
er
slow
anterograd
traffic
cell
pdmp
effect
like
pdmp
exert
effect
caus
accumul
ceramid
group
found
variou
effect
pdmp
activ
analogu
concomit
uemura
et
al
shayman
et
al
rani
et
al
actual
caus
increas
ceramid
concentr
abe
et
al
poss
de
chave
et
al
cell
treat
pdmp
h
measur
increas
newli
synthes
ceramid
fig
show
least
correl
level
newli
synthes
ceramid
effect
pdmp
protein
traffic
local
fact
pretreat
either
block
synthesi
ceramid
amelior
effect
pdmp
demonstr
ceramid
least
part
mediat
effect
howev
effect
pdmp
complet
abolish
pretreat
even
though
pretreat
reduc
level
newli
synthes
ceramid
compar
control
one
explan
ceramid
accumul
one
way
pdmp
exert
effect
anoth
possibl
ceramid
gener
degrad
preexist
sphingolipid
eg
cell
surfac
lysosom
ceramid
made
back
sphingolipid
enzym
sm
glccer
synthas
inhibit
presenc
pdmp
interestingli
fluorograph
ceramid
band
gener
variou
treatment
fig
b
show
differ
rel
amount
ceramid
speci
suspect
ceramid
differ
acyl
chain
length
abe
et
al
may
indic
differ
sourc
ceramid
ie
de
novo
synthesi
sphingolipid
degrad
current
investig
possibl
base
pretreat
result
expect
solubl
analogu
ceramid
would
mimic
effect
pdmp
rosenwald
pagano
show
like
pdmp
c
cer
decreas
rate
transit
itiner
protein
medialgolgi
cho
cell
consist
result
c
cer
also
slow
anterograd
traffic
cell
howev
c
cer
effect
local
either
protein
shortchain
ceramid
analogu
c
c
ceramid
also
effect
ibv
local
fit
model
ceramid
mediat
pdmp
effect
one
explan
effect
protein
local
independ
effect
anterograd
traffic
rate
case
may
c
cer
endogen
ceramid
similar
abil
bind
affect
protein
regul
anterograd
traffic
c
cer
unabl
bind
affect
protein
regul
protein
local
shown
short
chain
analogu
ceramid
effect
endogen
ceramid
eg
wolff
et
al
second
possibl
effect
ceramid
limit
bilay
concentr
increas
differ
seen
endogen
ceramid
exogen
c
cer
due
differ
intracellular
distribut
molecul
c
cer
would
unlik
accumul
compart
ibv
ergic
resid
rapidli
convert
sphingolipid
rosenwald
et
al
effect
membran
traffic
might
dramat
compart
c
cer
accumul
possibl
transgolgi
tgn
pagano
et
al
consist
idea
rate
movement
vsv
g
late
golgi
measur
sialyl
slow
much
greater
extent
c
cer
pdmp
rosenwald
pagano
yet
clear
ceramid
induc
chang
anterograd
traffic
protein
local
recent
studi
shown
ceramid
hannun
metabolit
hakomori
play
major
role
second
messeng
preliminari
experi
ceramidas
inhibitor
noleoylethanolamin
exogen
ad
sphingosin
suggest
ceramid
breakdown
product
sphingosin
play
role
local
ibv
maceyka
c
macham
unpublish
observ
ceramid
activ
cytosol
protein
phosphatas
dobrowski
hannun
wolff
et
al
inhibit
okada
acid
preliminari
experi
suggest
okada
acid
block
pdmpinduc
chang
maceyka
c
macham
unpublish
observ
ceramid
could
activ
protein
kinas
mathia
et
al
kinas
fulli
character
anoth
possibl
increas
ceramid
within
lipid
bilay
directli
affect
local
ibv
earlier
work
laboratori
show
first
transmembran
domain
ibv
target
chimera
cgn
swift
macham
macham
et
al
possibl
cgn
bilay
distinct
lipid
domain
domain
contain
differ
set
protein
analog
glycosphingolipid
raft
segreg
membran
protein
involv
vesicular
traffic
snare
would
lead
mobil
immobil
domain
hypothes
normal
condit
ibv
would
target
immobil
domain
escap
molecul
would
cycl
back
er
elev
level
ceramid
could
disrupt
immobil
lipid
domain
induc
ibv
cycl
altern
perhap
ceramid
bind
ibv
transmembran
domain
prevent
interact
immobil
lipid
domain
